53515-36-9 Usage
Uses
Used in Pharmaceutical and Agrochemical Industries:
4-(2-Aminoethyl)thiomorpholine is used as a key intermediate in the synthesis of various pharmaceuticals and agrochemicals for its ability to contribute to the development of new drugs and pesticides. Its unique structure allows for the creation of a wide range of compounds with different therapeutic and pesticidal properties.
Used in Drug Discovery and Development:
As a versatile intermediate, 4-(2-Aminoethyl)thiomorpholine is used in drug discovery and development to create novel compounds with potential therapeutic applications. Its presence in the molecular structure can influence the pharmacological properties of the resulting drugs, contributing to the advancement of medicine.
Used in Organic Synthesis:
4-(2-Aminoethyl)thiomorpholine is utilized as a reagent in organic synthesis, where it can participate in various chemical reactions to form a multitude of organic compounds. Its dual functionality with an amino and thiol group makes it a valuable component in the synthesis of complex organic molecules.
Used in Anticonvulsant and Antimicrobial Research:
4-(2-Aminoethyl)thiomorpholine is studied for its potential as an anticonvulsant and antimicrobial agent. It is used in research to explore its effects on seizure activity and its ability to inhibit the growth of microorganisms, which could lead to the development of new treatments for epilepsy and infectious diseases.
Check Digit Verification of cas no
The CAS Registry Mumber 53515-36-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,3,5,1 and 5 respectively; the second part has 2 digits, 3 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 53515-36:
(7*5)+(6*3)+(5*5)+(4*1)+(3*5)+(2*3)+(1*6)=109
109 % 10 = 9
So 53515-36-9 is a valid CAS Registry Number.
InChI:InChI=1/C6H14N2S/c7-1-2-8-3-5-9-6-4-8/h1-7H2/p+2
53515-36-9Relevant academic research and scientific papers
Preparation and antitumor activity of additional mitomycin A analogues
Sami,Remers,Bradner
, p. 703 - 708 (2007/10/02)
On the basis of qualitative structure-activity relationships developed in the preceding article, a series of 32 new mitomycin A analogues were prepared and tested in antitumor screens. Seven of them gave greater prolongation of life (ILS) than mitomycin C in the mouse P388 leukemia assay. They included examples with 7-O substituents such as cyclic ethers and nitrogen heterocycles. A Hansch analysis was attempted with log P and MR as the independent variables, but no statistically significant correlation could be made. Seven compounds, chosen mainly for their good potency (MED), were tested in the subcutaneous B16 melanoma assay in mice and four of them showed greater ILS than mitomycin C.
